Guangzhou Kingmed Diagnostics Group Co., Ltd. (SHA: 603882)

Guangzhou Kingmed Diagnostics Group Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 5, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	12,893	29,331	36,530	51,852	58,870	23,453
Market Cap Growth	-64.18%	-19.71%	-29.55%	-11.92%	151.01%	129.89%
Enterprise Value	11,979	28,042	34,610	50,765	58,143	23,339
Last Close Price	27.74	60.77	74.09	103.91	119.27	47.61
PE Ratio	29.01	44.03	12.56	21.83	36.47	54.10
PS Ratio	1.58	3.43	2.36	4.34	7.14	4.45
PB Ratio	1.69	3.43	4.12	7.95	15.19	10.08
P/FCF Ratio	46.15	56.83	32.99	45.66	60.54	60.68
P/OCF Ratio	13.87	23.83	18.75	24.83	38.65	35.46
EV/Sales Ratio	1.45	3.28	2.24	4.25	7.05	4.43
EV/EBITDA Ratio	16.77	32.63	9.41	16.61	28.14	33.61
EV/EBIT Ratio	79.00	67.58	10.60	18.64	32.57	53.30
EV/FCF Ratio	42.88	54.34	31.26	44.71	59.79	60.39
Debt / Equity Ratio	0.09	0.07	0.06	0.10	0.11	0.26
Debt / EBITDA Ratio	0.98	0.59	0.15	0.20	0.20	0.89
Debt / FCF Ratio	2.52	1.12	0.51	0.55	0.43	1.59
Asset Turnover	0.70	0.67	1.26	1.37	1.49	1.26
Inventory Turnover	21.40	16.60	23.46	21.59	21.46	21.33
Quick Ratio	2.81	2.95	2.22	2.02	1.93	1.56
Current Ratio	2.96	3.07	2.33	2.13	2.06	1.70
Return on Equity (ROE)	5.34%	7.31%	36.95%	45.46%	50.74%	19.40%
Return on Assets (ROA)	0.81%	2.02%	16.57%	19.58%	20.22%	6.55%
Return on Capital (ROIC)	1.08%	2.79%	24.61%	29.77%	30.85%	9.70%
Earnings Yield	3.45%	2.19%	7.54%	4.28%	2.56%	1.72%
FCF Yield	2.17%	1.76%	3.03%	2.19%	1.65%	1.65%
Dividend Yield	3.17%	1.45%	2.40%	1.23%	0.28%	0.29%
Payout Ratio	93.34%	130.46%	22.13%	7.66%	6.09%	21.76%
Buyback Yield / Dilution	-0.38%	0.15%	-0.13%	-1.00%	-0.98%	0.07%
Total Shareholder Return	2.79%	1.60%	2.27%	0.23%	-0.71%	0.35%

Source: S&P Capital IQ. Standard template. Financial Sources.